KODIAK SCIENCES INC (KOD)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for KOD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| KOD | Director; Board Member | 72 | ["Former Executive Vice President of Pharmaceutical Development and Manufacturing at Gilead Sciences, Inc.","Directed operations of chemical and biologics process development, device and formulation development, and site operations.","Developed the world’s first HIV single tablet regimen and advanced over 25 compounds to market.","Bachelor’s degree in Chemistry from National Taiwan University.","Ph.D. in Organic Chemistry from the University of Southern California.","Fellow of the American Institute for Medical and Biological Engineering (2021).","Member of the National Academy of Engineering (2022)."] | ["Audit"] | 2026 |